First Manhattan’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-100
Closed -$12K – 1604
2021
Q3
$12K Buy
+100
New +$11.9K ﹤0.01% 1245
2020
Q4
– Sell
-33
Closed -$3K – 1359
2020
Q3
$3K Buy
+33
New +$3.02K ﹤0.01% 1241

Other funds holding GH

First Manhattan's GH Position: Q4 2021 in Review

First Manhattan sold out of Guardant Health (GH) in Q4 2021, closing a stake of 100 shares — an estimated $12K sold.

First Manhattan first reported a position in GH in Q3 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • First Manhattan reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • First Manhattan sold 100 Guardant Health shares in Q4 2021, an estimated $12K.
  • First Manhattan first reported a position in Guardant Health in Q3 2020 and held it in 2 quarters.
  • First Manhattan's Guardant Health position peaked at $12K in Q3 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on First Manhattan's 13F filing for Q4 2021, filed 14 Feb 2022.